



























hVaccine 32 (2014) 48–53
Contents lists available at ScienceDirect
Vaccine
journa l homepage: www.e lsev ier .com/ locate /vacc ine
rotein-energy malnutrition alters IgA responses to rotavirus
accination and infection but does not impair vaccine
fﬁcacy in mice 
lizabeth A. Maiera,1, Kristina J. Weagea,1, Marjorie M. Guedesa, Lee A. Densona,
onica M. McNealb, David I. Bernsteinb, Sean R. Moorea,c,∗
Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, OH, USA
Infectious Diseases, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, OH, USA
Center for Global Child Health, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, OH, USA
r t i c l e i n f o
rticle history:
eceived 27 August 2013
eceived in revised form 16 October 2013
ccepted 23 October 2013






pizootic diarrhea of infant mice
nvironmental enteropathy
a b s t r a c t
Background:Conﬂicting evidence linksmalnutrition to the reduced efﬁcacy of rotavirus vaccines in devel-
oping countries, where diarrhea and undernutrition remain leading causes of child deaths. Here, we
adapted mouse models of rotavirus vaccination (rhesus rotavirus, RRV), rotavirus infection (EDIM), and
protein-energy malnutrition (PEM) to test the hypothesis that undernutrition reduces rotavirus vaccine
immunogenicity and efﬁcacy.
Methods:Werandomizedwild typeBalb/Cdamswith3-day-oldpups toa controldiet (CD)or an isocaloric,
multideﬁcient regional basic diet (RBD) that produces PEM. At 3 weeks of age, we weaned CD and RBD
pups to their dams’ diet and subrandomizedweanlings to receive a single dose of either live oral rotavirus
vaccine (RRV) or PBS. At 6 weeks of age, we orally challenged all groups with murine rotavirus (EDIM).
Serum and stool specimens were collected before and after RRV and EDIM administration to measure
viral shedding and antibody responses by ELISA.
Results: RBD pups and weanlings exhibited signiﬁcant failure to thrive compared to age-matched CD
mice (P< .0001). RRV vaccination induced higher levels of serum anti-RV IgA responses in RBD vs. CD
mice (P< .0001). Vaccination protected CD and RBD mice equally against EDIM infection, as measured
by viral shedding. In unvaccinated RBD mice, EDIM shedding peaked 1 day earlier (P< .05), however we
detected no effects of undernutrition on viral clearance nor of infection on bodyweight. EDIM infection
provoked higher anti-RV serum IgA levels in RBD vs. CD mice, regardless of vaccination (P< .0001). Last,
RRV vaccination mitigated stool IgA responses to EDIM more in CD vs. RBD mice (P< .0001).
Conclusions: Despite modulated IgA responses to vaccination and infection, undernutrition does not
impair rotavirus vaccine efﬁcacy nor exacerbate infection in this mouse model of protein-energy malnu-
trition. Alternative models are needed to elucidate host-pathogen factors undermining rotavirus vaccine
globeffectiveness in high-riskAbbreviations: RRV, rhesus rotavirus vaccine; EDIM, epizootic diarrhea of infant
ice; RV, rotavirus, ELISA.
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1. Introduction
Rotavirus is the most common cause of severe diarrhea in
children under 5 years of age and the leading cause of diarrheal
deaths worldwide. [1–5]. Over 90% of global child deaths from
rotavirusoccur in low-incomecountries, predominantly inAsia and
Africa [4,6]. The increased mortality in these settings is generally
attributed to an unacceptably high prevalence of child undernutri-
tion and limited access to medical care [7,8].
Rotavirus immunization has emerged as a key component of
Open access under CC BY license.global strategies to reduce childhood deaths from diarrhea [9].
The two currently available rotavirus vaccines (RotarixTM and
RotaTeqTM) produce high rates of seroconversion (85–98%) and
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tates andEurope [10]; however, theydonotprovide anequalmea-
ure of protection in the developing world [11,12]. For example,
ean seroconversion for RotarixTM is 75% in lower-middle and 63%
n low-income countries and was only 57% in Malawi, prompting
he question as to what extent will rotavirus vaccines work where
hey are needed most [10,13,14]. Subsequent reports by Zaman
t al. and Armah et al. of rotavirus vaccine trials in Asia and sub-
aharanAfrica foundefﬁcacyagainst severediarrhea tobeonly48.3
nd 39.3%, respectively [15,16].
The decreased efﬁcacy of live oral vaccines in developing
ountries—a phenomenon known as the “tropical barrier”—is con-
trained to neither rotavirus nor the tropics [2,6,11,17–20]. Host
eterminants of the tropical barrier are still unknown, however
efects in innate and adaptive immunity due to high rates of child
ndernutrition, inadequate levels of sanitation and hygiene, tropi-
al/environmental enteropathy, andnatural selection for resistance
o enteric pathogens have all been proposed to play an important
ole [6,21–28].
To date, few clinical studies have investigated the impact of
ndernutrition on rotavirus vaccine efﬁcacy. Linhares and col-
eagues found that undernourished Brazilian children were less
rotected from rotavirus and all-cause diarrhea following admin-
stration of low-dose RotaShieldTM vaccine [29]. A more recent
ulticountry analysis by Perez-Schael et al. found that RotarixTM
rotected children against rotavirus infection regardless of nutri-
ional status [30]. Lastly, a prospective cohort study of the effects
f undernutrition and environmental enteropathy on rotavirus
nd polio vaccine efﬁcacy is currently underway in Bangladesh
www.providestudy.org]. To complement these clinical studies, we
ested the effects of rhesus rotavirus (RRV) vaccine and murine
otavirus (EDIM) challenge responses in our recently described
urine model of undernutrition with features of environmental
nteropathy [31,32].
Formulated by Teodósio and colleagues to reﬂect dietary deﬁ-
iencies of impoverished populations in northeastern Brazil with
rotein energymalnutrition (PEM), the regional basic diet (RBD) is a
esearch dietmoderately deﬁcient in fat, protein, andminerals that
nduces PEM in rodents [33]. We have recently shown that a semi-
uriﬁed RBD produces failure to thrive, small intestinal mucosal
trophy and gut barrier dysfunction in mice [31]. We hypothesized
hat undernutrition caused by the regional basic diet would impair
he efﬁcacy of oral rotavirus immunization and that undernutrition
xacerbates rotavirus infection in weanling mice. Here we report
hat: (1) Despite altered antibody responses following murine
otavirusEDIMchallenge, oral rotavirusvaccinationappears toade-
uately protect undernourishedmice against sheddingof rotavirus,
2) In undernourished mice, anti-rotavirus IgA levels are altered
n both immunized and unimmunized mice following EDIM chal-
enge, and (3) Unimmunized, undernourished mice produce lower
evels of anti-rotavirus IgG in response to EDIM infection.
. Methods
.1. Viruses
The rhesus rotavirus (RRV) strainused in this studywasobtained
rom Dr. Harry Greenberg (Stanford University, Palo Alto, CA). The
urine rotavirus strain EDIM was originally obtained from M.
ollins (Microbiological Associates, Bethesda, MD). Both viruses
ere passaged in the African green monkey kidney MA-104 cell
ine. Viruses were titered in this same cell line using a ﬂuorescent
ocus assay as previously described [34]..2. Murine model of undernutrition
Timed pregnant BALB/c mice were purchased from Harlan Lab-
ratories (Indianapolis, IN). All mice were housed in microisolation32 (2014) 48–53 49
cages and shown to be rotavirus-negative by serology prior to use.
Adoptions were set up to allocate 6 to 7 pups per cage. Fourteen
dams of 3-day-old pups were randomized to an ad lib puriﬁed con-
trol diet (Control: 15% fat, 20% protein, 65% CHO) or an isocaloric
regional basic diet (RBD: 5% fat, 7% protein, 88% CHO) to induce
weanling undernutrition, as previously described [29]. Both diets
were irradiated prior to administration. Beginning on day of life
(DOL) 3,micewereweighed every three days. OnDOL21pupswere
weaned to their dams’ diet (3,4 mice per cage) and body weights
were recorded weekly. All animal procedures were conducted in
accordance with the Cincinnati Children’s Hospital Research Foun-
dation Institutional Animal Care and Use Committee.
2.3. RRV vaccination
On DOL 21, 86 weanlings received a single dose
(1.0×107 ffu/ml) of RRV by oral gavage (vaccine) or PBS sham. To
determine shedding of RRV, two fecal pellets were collected by
massage from each mouse individually at days 2, 3, and 4 after
immunization and kept in 1ml of Earle’s balanced salt solution
(EBSS). Samples were stored frozen until analyzed, at which time
they were homogenized and centrifuged to remove debris. Three
weeks later, animals were bled from the orbital sinus and stool was
collected for antibody analysis. Serum samples were centrifuged
10min at 400×g and the sera was stored at −20 ◦C. Rotavirus
antigen and antibody levels, including total and rotavirus speciﬁc
levels, were then quantiﬁed using ELISA as described previously
described [35]
2.4. EDIM challenge and detection of viral shedding and
antibodies
Threeweeks following vaccination (week 6), all pupswere chal-
lengedbyoral gavagewithmurine rotavirusEDIMstrain at adoseof
4 × 104 ffu (focus-forming units), or 105 shedding dose 50. Tomea-
sure rotavirus shedding, two fecal pellets were collected from each
mouse each day for 7days following EDIM challenge and processed
as described above. Serum and two fecal pellets were collected
immediately prior to challenge (week 6) for analysis of pre-EDIM
antibody titers and again at week 9 for analysis of post-EDIM titers.
We did not test sera for viremia.
2.5. Statistical methods
All statistical analyses were performed using the statistical
software package GraphPad Prism, version 5. A two-sample t
test was used when two groups were compared. ANOVA was
used when more than two groups were compared, with Bonfer-
roni corrections for multiple comparisons of anti-rotavirus and
total antibody corrected immunoglobulin levels. Mann–Whitney
U and Kruskal–Wallis tests were used compare data sets with non-
parametric data as determined by a D’Agostino–Pearson normality
test. Two-sided P values less than the Bonferroni corrected values
were considered statistically signiﬁcant.
3. Results
3.1. The regional basic diet (RBD) produces failure to thrive in
pups and weanlings
We randomized dams of 3-day-old litters to a puriﬁed control
diet (CD: 15% fat, 20% protein, 65% CHO, N=7) or an isocaloric
regional basic diet (RBD: 5% fat, 7% protein, 88% CHO, N=7) for-
mulated to induce protein energy malnutrition (Fig. 1). All pups of
RBD dams showed reduced weight (Fig. 2A) by DOL 9 compared to
pupsof CDdamsand remainedunderweight at the timeof bothRRV
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Fig. 1. Experimental design for comparing rotavirus immunization (RRV) and chal-
lenge (EDIM) responses in mice undernourished by a multideﬁcient regional basic
diet (RBD). We randomized dams of 3-day-old litters to a puriﬁed control diet (CD:
15% fat, 20% protein, 65% CHO, N=7) or an isocaloric, regional basic diet (RBD: 5%
fat, 7% protein, 88% CHO, N=7) formulated to induce protein-energy malnutrition.
At 3 weeks of age, we weaned CD and RBD pups to their dams’ diet and subrandom-



















cr PBS. At 6 weeks of age, we orally challenged all groups with murine rotavirus
EDIM). Serum and stool specimens were collected before and after RRV and EDIM
dministration to measure viral shedding and antibody responses by ELISA.
noculation and EDIM challenge (Fig. 2B; P< .0001 by RM ANOVA).
BD dams lost weight relative to CD dams as early as pup DOL 9
nd continued to lose weight until weaning (data not shown).
.2. Serum and stool antibody responses to RRV immunization in
BD vs. CD mice
To determine the effects of undernutrition on mouse responses
o rotavirus vaccination, 22-day-old RBD and CD weanlings were
mmunizedwith either RRV (1.0×107 ffu/ml,N=47) or PBS (N=39)
y oral gavage. RRV shedding was detectable in only 1 of 23 and 2
ig. 2. Regional Basic Diet (RBD) produces failure to thrive in suckling and wean-
ing pups. (A) Mean bodyweight of suckling pups, day of life 3–21, whose dams
eceived a control diet (CD) or RBD. Pups of RBD dams diet failed to thrive compared
o pups of CD dams (*P< .0001 by RM ANOVA). N=43 mice per group. Error bars
epresent standard deviations. (B) Pups were weaned to their dams’ diet on DOL
1. RBD mice remained underweight relative to age-matched controls (*P< .0001
y RM ANOVA). Mouse weights were inﬂuenced neither by vaccination nor EDIM
hallenge. N=19–24 mice per group. Error bars represent standard error.32 (2014) 48–53
of 24 vaccinated CD and RBDmice, respectively. In separate experi-
ments, we tested a 3-fold higher dose of RRV (3.0×107 ffu/ml) and
detected viral shedding in 50% of all mice, regardless of nutritional
status (data not shown). To prevent over-immunization and mask-
ing potential effects of undernutrition onRRV-protection,we chose
to perform our study with the original (1.0×107 ffu/ml) RRV dose.
Comparing the response to RRV vaccine in RBD vs. CD ani-
mals by antibody levels obtained at week 6 (just prior to EDIM
challenge) revealed that both anti-RV IgG and sera anti-RV IgA
were increased in RBD mice relative to CD mice (Fig. 3A and
B), however this difference was not signiﬁcant when correct-
ing for increases in total IgG and total sera IgA in RBD mice
(Fig. 3D and E). We detected no difference in anti-RV stool IgA
between CD and RBD mice (Fig. 3C); however, total stool IgA was
decreased in RBD mice relative to CD mice (2208±188mg/ml
vs. 5155±425mg/ml; P<0.0001) (Fig. 3F). Total serum IgA was
increased in RBD mice compared to controls in both vaccinated
andunvaccinated groups (4772±609mg/ml vs. 2812±265mg/ml,
P<0.01; 4248±279mg/ml vs. 2403±208mg/ml, P<0.05; Fig. 3E).
3.3. Rotavirus vaccine protects undernourished and nourished
mice equally against EDIM
Todetermine theextent towhichundernutrition inﬂuencespro-
tection from EDIM infection and viral replication in immunized vs.
unimmunized and nourished vs. undernourished mice, we chal-
lenged all 4 experimental groups with murine rotavirus (EDIM)
by oral gavage at 6 weeks of age and collected stool for 7 days
immediately post-challenge. Rotavirus vaccine was highly efﬁca-
cious in both nourished and undernourished mice. As shown in
Fig. 4, we observed a signiﬁcant reduction in virus shedding in
RRV-immunized RBD and CDmice compared to unimmunized con-
trols. In unimmunized mice, peak intensity of infection occurred
1 day earlier in the RBD group (Fig. 4). Day 2 after EDIM chal-
lenge, viral shedding was 1917±487ng/ml for control mice and
5018±622ng/ml for RBD mice (P<0.001) while on Day 3, viral
sheddingwas4708±580ng/ml for controlmiceand2361±374/ml
for RBD mice (P<0.01).
3.4. Serum and stool antibody responses to EDIM challenge in
undernourished mice
We detected no differences in titers of anti-RV serum IgG, anti-
RV stool IgA, total serum IgG and total serum IgA following EDIM
challenge in unvaccinated RBD and CD mice (Fig. 5A, C, D, and F).
Moreover, we found no differences in levels of anti-RV serum IgG
and anti-RV stool IgA between vaccinated RBD and CDmice (Fig. 5A
and C). In contrast, both immunized and unimmunized RBD mice
exhibited signiﬁcantly higher mean anti-RV serum IgA relative to
nourished controls (P< .0001 by ANOVA, Fig. 5B). Unvaccinated
RBD mice showed signiﬁcant increases in total serum IgA (Fig. 5E,
P<0.01). Furthermore, in immunizedRBDmice ahigher percentage
of rotavirus stool IgA was speciﬁc for RV following EDIM challenge
relative to nourished controls (mean of 23% vs. 9%; P<0.001 by
ANOVA corrected for total IgA).
4. Discussion
In this ﬁrst ever study of effects of weanling undernutrition on
immune responses to both rotavirus immunization (RRV) and chal-
lenge (EDIM) we ﬁnd that oral rotavirus vaccination adequately
protects mice against EDIM despite altered antibody responses
to vaccination and challenge. In addition, we show that serum
anti-rotavirus IgA levels are elevated in both immunized and
unimmunized undernourished mice following EDIM infection. We
further demonstrate that unimmunized, undernourished mice
E.A. Maier et al. / Vaccine 32 (2014) 48–53 51
Fig. 3. ELISA quantiﬁcation of serum and stool anti-rotavirus and total serum antibodies before rotavirus (EDIM) challenge. Unvaccinated control diet (RBD−, RRV, solid
























mRV+, open black circles) and vaccinated regional basic diet (RBD+, RRV+, open gre
era anti-RV IgA, (C) stool anti-RV IgA, (D) sera total IgG, (E) sera total IgA, and (F)
= 19–24 mice per group. Error bars represent standard error. (***P<0.001, **P<0.
hed rotavirus more rapidly than unimmunized, nourished mice.
trikingly, we ﬁnd that in immunized RBD mice anti-RV stool IgA
akes up a higher percentage of the total stool IgA compared to CD
ice, both pre- and post-EDIM challenge.
Similar to secondary analyses of clinical trial data conducted
y Parez-Schael et al., we found that malnutrition alone does not
mpair the efﬁcacy of rotavirus immunization [30]. The strengths
f our laboratory study design allowed us to examine undernu-
rition, rotavirus immunization, and rotavirus infection, alone and
n combination, with appropriate controls for age and diet. One
otential limitation of our study design is that we did not pair feed
ice. Pair feeding of control mice, instead of ad libitum access to an
socaloric control diet, would have further strengthened our design
y controlling for potential effects of amount of rations consumed.
We predicted that undernourished mice would be more sus-
eptible to rotavirus replication and have more severe disease,
ig. 4. The regional basic diet (RBD) accelerates rotavirus shedding in under-
ourished mice but does not impair rotavirus vaccine-acquired immunity. ELISA
easurements of stool rotavirus antigen following EDIM challenge at age 9 weeks
n undernourished (RBD, triangles) and nourished (control diet (CD), circles) mice,
nvaccinated (dotted lines) or vaccinated (solid lines) at age 3 weeks with RRV.
eak rotavirus shedding occurred 1 day earlier in undernourished, unvaccinated
ice (P< .05). N=19–24 mice per group. Error bars represent standard error.ngles) weanling mice were vaccinated with RRV DOL 21. (A) Sera anti-RV IgG, (B)
otal IgA. Serum and stool were collected one day before EDIM challenge (week 6).
< 0.05).
however this was clearly not the case. As previously observed
by Offor et al. in malnourished suckling mice [36], we found
accelerated rotavirus shedding in undernourished mice, however
both undernourished and nourished animals were able to clear
rotavirus effectively. These later results stand in contrast to ﬁnd-
ings by Guerrant and co-workers that report more severe disease
and exacerbation of malnutrition when undernourished mice are
infected with Cryptosporidium [37], Giardia, [38] and enteroag-
gregativeE. coli [39]. Of note, by choosing to challenge adult mice,
our models were better designed to examine rotavirus infection
and shedding rather than frank diarrhea—a response limited to
EDIM infection of young mice. Additional host factors that might
account for the divergence of our ﬁndings from other published
mouse models of malnutrition and gut infection include mouse
strain and the method by which undernutrition is induced, e.g.,
caloric restriction vs. multideﬁcient diets vs. timed separations of
pups from dams.
To our knowledge, the “vicious cycle” of diarrhea and under-
nutrition has not yet been deﬁnitively recapitulated in rodent
models of viral diarrhea. In addition, the ﬁndings of our mouse
study parallel results of a large case–control study of diarrhea
hospitalizations in Bangladesh, which found that children admit-
ted with rotavirus-positive diarrhea had better nutritional status
than children admitted for parasitic or bacteria-associated diar-
rheal illnesses [40]. Another recent mouse study also found that
underweight mice had one less day of diarrhea as compared to
their normal-weight andoverweight counterparts [41]. The current
animal data, together with previously published clinical ﬁndings,
suggest that undernutrition may indeed be an important risk
factor for initial or even repeat rotavirus infections, but that mild-
to-moderate malnutrition is not a signiﬁcant contributor to the
severity of rotavirus infections.
When nourished and undernourished mice were vaccinated
with RRV, we found no group differences in viral clearance fol-
lowing EDIM challenge; however, we did detect group differences
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Fig. 5. ELISA quantiﬁcation of serum and stool anti-rotavirus and total serum antibodies following rotavirus (EDIM) challenge. Unvaccinated control diet (RBD−, RRV−, solid






































2004;39(Suppl 2):S662–9.RV−, open black circles) and vaccinated regional basic diet (RBD+, RRV+, open gr
era anti-RV IgA, (C) stool anti-RV IgA, (D) sera total IgG, (E) sera total IgA, and (F)
ice per group. Error bars represent standard error.
n serum and stool antibody responses. Lower levels of total
tool IgA in RBD vaccinated mice compared to CD mice might
e explained by a deﬁciency of mucosal IgA production or trans-
ort secondary to a delay in maturation of the secretory IgA
ystem due to protein malnutrition, as reported by Green and
eyworth [42]. Our ﬁnding of increased serum IgA and IgG in
BD-fed mice is also supported by the work of Neumann et al.
ho described increases in these immunoglobulins in malnour-
shed children [43].Wehave previously described intestinal barrier
efects in mice fed the regional basic diet that parallel those seen
n children with environmental enteropathy, hence gut-to-blood
acterial translocation leading to a systemic immune response and
levations in serum immunoglobulins may explain our current
ndings [31].
Three decades after the ﬁrst trial of a live oral rotavirus vac-
ine candidate, rotavirus immunizations are now a key component
f global strategies to reduce childhood deaths from diarrhea [9].
lthough global malnutrition remains the most common cause of
uman immunodeﬁciency worldwide and is known to alter cellu-
ar mediated immunity, the complement system, and phagocytosis
44], malnutrition alone did not recapitulate the “tropical barrier”
n our model. Alternative explanations for the tropical barrier—and
trategies to optimize live oral vaccine response in the developing
orld—will require intensive additional study. Preclinical mod-
ls of co-infection with other pathogens such as helminths [45],
icronutrient deﬁciencies [46], small bowel bacterial overgrowth
20],maternal antibodies [47], andenvironmental enteropathy [18]
ll merit further consideration.
We conclude that rotavirus vaccination protects nourished and
ndernourished mice equally against rotavirus infection, despite
igniﬁcant differences in antibody responses to immunization and
hallenge. Further laboratory and clinical studies are urgently
eeded to elucidate host, pathogen, and environmental factors
nderlying the impaired efﬁcacy of rotavirus vaccines in the devel-
ping world in order to continue to improve outcomes for the
orld’s most vulnerable children [48].
[ngles) weanling mice were vaccinated with RRV DOL 21. (A) Sera anti-RV IgG, (B)
otal IgA. Serum and stool were collected post-EDIM challenge (week 9). N=19–24
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